Thalidomide in the Treatment of Immune Reconstitution Inflammatory Syndrome in HIV Patients with Neurological Tuberculosis
2014; Mary Ann Liebert, Inc.; Volume: 28; Issue: 11 Linguagem: Inglês
10.1089/apc.2014.0083
ISSN1557-7449
AutoresC. R. Fourcade, Jean‐Marc Mauboussin, Catherine Lechiche, Jean‐Philippe Lavigne, Albert Sotto,
Tópico(s)Orthopedic Infections and Treatments
ResumoAIDS Patient Care and STDsVol. 28, No. 11 Letter to the EditorThalidomide in the Treatment of Immune Reconstitution Inflammatory Syndrome in HIV Patients with Neurological TuberculosisCamille Fourcade, Jean-Marc Mauboussin, Catherine Lechiche, Jean-Philippe Lavigne, and Albert SottoCamille FourcadeInfectious and Tropical Diseases Unit, Nîmes University Hospital, Nîmes, France.Search for more papers by this author, Jean-Marc MauboussinInfectious and Tropical Diseases Unit, Nîmes University Hospital, Nîmes, France.Search for more papers by this author, Catherine LechicheInfectious and Tropical Diseases Unit, Nîmes University Hospital, Nîmes, France.Search for more papers by this author, Jean-Philippe LavigneDepartment of Microbiology, Nîmes University Hospital, Nîmes, France.Search for more papers by this author, and Albert SottoInfectious and Tropical Diseases Unit, Nîmes University Hospital, Nîmes, France.Search for more papers by this authorPublished Online:3 Nov 2014https://doi.org/10.1089/apc.2014.0083AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byOutcome of Lenalidomide Treatment for Cognitive Impairment Caused by Immune Reconstitution Inflammatory Syndrome in Patients with HIV-Related Cryptococcal Meningitis1 September 2022 | Journal of Inflammation Research, Vol. Volume 15Immunomodulatory effects of thalidomide in an experimental brain death liver donor model28 September 2021 | Scientific Reports, Vol. 11, No. 1Thalidomide in the treatment of human immunodeficiency virus-negative tuberculous meningitis2 October 2020 | Medicine, Vol. 99, No. 40Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis23 October 2020 | Medicine, Vol. 99, No. 43Neurological TB in HIV1 December 2019Clinical perspectives into the use of thalidomide for central nervous system tuberculosis18 July 2018 | European Journal of Neurology, Vol. 25, No. 11Use of Embryoid Bodies for the Detection of Teratogens and Analysis of Teratogenic Mechanisms16 April 2018Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?EBioMedicine, Vol. 24Thalidomide and its analogues: A review of the potential for immunomodulation of fibrosis diseases and opthalmopathy (Review)27 September 2017 | Experimental and Therapeutic MedicineThalidomide/isoniazid26 September 2015 | Reactions Weekly, Vol. 1570, No. 1Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review10 April 2015 | Expert Review of Anti-infective Therapy, Vol. 13, No. 6 Volume 28Issue 11Nov 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Camille Fourcade, Jean-Marc Mauboussin, Catherine Lechiche, Jean-Philippe Lavigne, and Albert Sotto.Thalidomide in the Treatment of Immune Reconstitution Inflammatory Syndrome in HIV Patients with Neurological Tuberculosis.AIDS Patient Care and STDs.Nov 2014.567-569.http://doi.org/10.1089/apc.2014.0083Published in Volume: 28 Issue 11: November 3, 2014Online Ahead of Print:October 6, 2014PDF download
Referência(s)